UK markets open in 5 hours 43 minutes

Celldex Therapeutics, Inc. (TCE2.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
36.60-1.20 (-3.17%)
At close: 08:12AM CEST
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts6655
Avg. Estimate-0.36-0.38-1.5-1.73
Low estimate-0.42-0.44-1.61-1.95
High estimate-0.32-0.35-1.43-1.51
Year ago EPS-0.5-0.36-2.02-1.5
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts5555
Avg. Estimate1.22M1.12M6.53M2.3M
Low estimateN/AN/A4.2MN/A
High estimate3.48M3.48M11.13M5M
Year ago sales390k3.79M7.42M6.53M
Sales growth (year/est)212.80%-70.40%-12.00%-64.80%
Earnings history30/06/202030/09/202031/12/202030/06/2021
Est. EPS-0.58-0.36-0.37-0.4
Actual EPS-0.5-0.36-0.55-0.34
Difference0.080-0.180.06
Surprise %13.80%0.00%-48.60%15.00%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.36-0.38-1.5-1.73
7 days ago-0.36-0.38-1.5-1.73
30 days ago-0.37-0.38-1.51-1.69
60 days ago-0.4-0.4-1.6-1.7
90 days ago-0.4-0.39-1.58-1.6
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesTCE2.FIndustrySector(s)S&P 500
Current qtr.28.00%N/AN/AN/A
Next qtr.-5.60%N/AN/AN/A
Current year25.70%N/AN/AN/A
Next year-15.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A